2025 National Dialogue Closing Day: Representatives from foreign companies such as Eli Lilly, Pfizer, and Bristol Myers Squibb enter the venue
According to reporters at the 2025 National Medical Insurance Catalog on-site negotiations and commercial insurance innovative drug catalog price negotiations, around 8 a.m. on the morning of the fifth day of the 2025 National Negotiation, Qian Yun, Vice President of Pfizer Global Biopharmaceutical Commercial Group for China, De He Lan, President and General Manager of Eli Lilly China, and representatives from Bristol Myers Squibb and other foreign companies began to enter. Reporters learned that today is the last day of the 2025 National Negotiation schedule, and the negotiation results are expected to be released in early December 2025
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments